Why iBio Stock Could Soar 500% Above Its Current Levels
The potential strength of IBIO stock is backed by promising technology and a well-connected partner
The biotech company is partnering with the Infectious Disease Research Institute (IDRI), on its Covid-19 vaccine. IDRI is part of the University of Washington, whose modeling has been used by the White House and NIH to predict the spread of coronavirus. Notably, IDRI has also received funding from the Bill & Melinda Gates Foundation. And iBio is also collaborating with Beijing-based CC-Pharming, potentially giving iBio the inside track to provide a Covid-19 vaccine to China.
Well if 3s come around , please post quickly I will load some more too...$IBIO